Related Experiment Video
Updated: May 27, 2026
06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Cough reflex in lung transplant recipients
Alexander G Duarte1, Allen C Myers
1Division of Pulmonary, Critical Care and Sleep Medicine, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555-0561, USA. aduarte@utmb.edu
Lung
|December 6, 2011
Summary
Lung transplant recipients may regain their protective cough reflex within 6-12 months. This neural recovery offers insights into airway healing and improved allograft survival after lung transplantation.
Area of Science:
- Pulmonary Medicine
- Neurosurgery
- Transplant Surgery
Background:
- Lung transplantation is a standard treatment for advanced lung disease.
- The procedure severs lower vagal nerve fibers, impairing the protective cough reflex.
- Impaired cough reflex increases the risk of lung allograft complications.
Purpose of the Study:
- To investigate the potential for recovery of the cough reflex after lung transplantation.
- To explore the implications of neural pathway restoration on allograft health.
- To understand the time-dependent processes of airway neural injury and repair.
Main Methods:
- Review of recent evidence on neural recovery post-lung transplantation.
- Analysis of functional and structural changes in airway neural pathways.
- Correlation of cough reflex status with allograft outcomes.
Main Results:
- Loss of the cough reflex after lung transplantation is not permanent.
- Functional and structural restoration of the cough reflex occurs 6-12 months post-transplant.
- Evidence suggests a dynamic neural repair process in the airways.
Conclusions:
- The cough reflex can be reestablished in lung transplant recipients.
- Neural recovery offers potential for improved allograft tissue repair.
- Understanding this dynamic response may enhance post-transplant care and outcomes.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...